AT BIOHAVEN, WE KNOW DAYS MATTER!
Biohaven is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas including neuroscience, immunology and oncology. In the pursuit of our mission, we know that patients are waiting and days matter. It’s why we operate with urgency and intention in applying cutting-edge science to turn breakthrough discoveries into best-in-class therapies for diseases with little or no treatment options.
PROVEN DELIVERY OF BEST‑IN‑CLASS TREATMENTS
Building upon our groundbreaking legacy of success transforming the treatment of migraine with Nurtec® ODT (rimegepant) and Zavzpret™ (zavegepant), Biohaven is advancing one of the industry’s most innovative therapeutic portfolios, leveraging our proven expertise in clinical execution and multiple, high value drug development platforms. Fueled by our entrepreneurial structure and experienced management team, we are advancing multiple late- and early-stage drug development programs in neuroscience, immunology and oncology for numerous diseases with significant unmet medical needs.
WE ARE SOCIAL
COMMITMENT TO PATIENTS
Patients are at the center of everything we do. Our commitment to them drives us to follow the path of science and motivates us to overcome the obstacles in bringing innovative medicines to those in need. It is all part of the patient-first culture we proudly call the “Biohaven Way.”
WINNING WITH SCIENCE
We’ve earned our reputation as a leader in scientific innovation. Through our five proprietary drug development platforms, we are pursuing novel paths of science to transform the treatment of a broad range of rare and common diseases. We are at the forefront of bold new areas of drug discovery and development.
CREATING SHAREHOLDER VALUE
Harnessing our culture of innovation and non-hierarchical entrepreneurial structure, Biohaven is focused on disrupting the status quo for historically difficult-to-treat diseases and creating extraordinary value for patients and shareholders.
OPTIMIZING VALUE THROUGH COLLABORATION & INNOVATION
Biohaven is continuously striving to evolve our approach to drug discovery and development to help people live healthier lives. To enhance our ability to deliver enduring value, we have combined internal research and development with intellectual property licensed from some of the world’s leading global companies and institutions.
OPTIMIZING VALUE THROUGH COLLABORATION & INNOVATION
Biohaven is continuously striving to evolve our approach to drug discovery and development to help people live healthier lives. To enhance our ability to deliver enduring value, we have combined internal research and development with intellectual property licensed from some of the world’s leading global companies and institutions.
SUCCEEDING TOGETHER
“Biohaven is deeply dedicated to scientific innovation in the pursuit of our ambitious mission to treat and prevent the most challenging diseases and improve lives. We operate at the forefront of neuroscience, immunology and oncology, resilient in our focus on following science and steadfast in our commitment to putting patients first. At Biohaven, the brightest minds come together in a unique culture of teamwork, collaboration, and accountability, working with intention and urgency to alleviate the burden of disease. There is no ceiling on what we can achieve!”
VLAD CORIC, M.D.
CHAIRMAN & CEO
VLAD CORIC, M.D.
CHAIRMAN & CEO
SUCCEEDING TOGETHER
“Biohaven is deeply dedicated to scientific innovation in the pursuit of our ambitious mission to treat and prevent the most challenging diseases and improve lives. We operate at the forefront of neuroscience, immunology and oncology, resilient in our focus on following science and steadfast in our commitment to putting patients first. At Biohaven, the brightest minds come together in a unique culture of teamwork, collaboration, and accountability, working with intention and urgency to alleviate the burden of disease. There is no ceiling on what we can achieve!”
